PRESS RELEASE published on 06/27/2024 at 09:45, 4 months 24 days ago PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance PharmaSGP Holding SE's Annual General Meeting approves full profit distribution for 2023 after successful business performance. Peter Gerckens appointed as Chief Commercial Officer Annual General Meeting Business Performance Profit Distribution PharmaSGP Holding SE Peter Gerckens
BRIEF published on 06/21/2024 at 07:35, 5 months ago PharmaSGP Holding SE renforce son conseil d'administration pour accélérer sa croissance Croissance Conseil D'administration PharmaSGP Peter Gerckens Chef De La Conformité
BRIEF published on 06/21/2024 at 07:35, 5 months ago PharmaSGP Holding SE Strengthens Management Board to Accelerate Growth Growth Management Board CCO PharmaSGP Peter Gerckens
PRESS RELEASE published on 06/21/2024 at 07:30, 5 months ago PharmaSGP Holding SE strengthens the Management Board to further accelerate growth PharmaSGP Holding SE strengthens Management Board with Peter Gerckens as Chief Commercial Officer to boost growth strategy Chief Commercial Officer Growth Management Board PharmaSGP Holding SE Peter Gerckens
BRIEF published on 05/14/2024 at 07:35, 6 months 7 days ago PharmaSGP annonce une forte croissance au premier trimestre 2024 Hausse Des Revenus Résultats Financiers Du Premier Trimestre 2024 PharmaSGP Produits Pharmaceutiques En Vente Libre Marchés Européens
BRIEF published on 05/14/2024 at 07:35, 6 months 7 days ago PharmaSGP Reports Strong Growth in Q1 2024 Revenue Growth European Markets PharmaSGP Q1 2024 Financials OTC Pharmaceuticals
PRESS RELEASE published on 05/14/2024 at 07:30, 6 months 7 days ago PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024 PharmaSGP Holding SE reports 25.6% revenue growth in Q1 2024, reaching €30.1 million. Adjusted EBITDA increased to €8.9 million with a margin of 29.4% Adjusted EBITDA Revenue Growth Q1 2024 PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 04/18/2024 at 20:36, 7 months 2 days ago PharmaSGP Holding SE Announces Increased Dividend for 2023 Annual General Meeting Financial Performance Dividend Increase Shareholder Return PharmaSGP
BRIEF published on 04/18/2024 at 20:36, 7 months 2 days ago PharmaSGP Holding SE annonce une augmentation de son dividende pour 2023 Performance Financière Augmentation Du Dividende Assemblée Générale Annuelle PharmaSGP Rendement Pour Les Actionnaires
PRESS RELEASE published on 04/18/2024 at 20:31, 7 months 2 days ago EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 PharmaSGP Holding SE proposes a significant increase in dividend to EUR 1.36 per share for 2023, totaling EUR 16,320,000.00. The company plans to adjust its dividend policy for future distributions 2023 Dividend Increase PharmaSGP Holding SE EUR 1.36
Published on 11/21/2024 at 14:15, 23 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 38 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 38 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 38 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 22 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 23 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 13:41, 57 minutes ago Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Published on 11/21/2024 at 06:58, 7 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 40 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 18 hours 31 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 19 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting